Healthcare — Pancreatic Cancer Study Offers New Treatment Insights

Healthcare · 2026-04-17

TODAY'S SIGNAL — Three distinct forces are reshaping healthcare this week. First, a potential paradigm shift in oncology: Revolution Medicines' daraxonrasib trial data in pancreatic cancer is being called a possible "new era" by leading oncologists, signaling that RAS-targeted therapies may finally crack one of the most intractable cancers. Second, the ACA coverage ecosystem is showing real…